Cargando…

GLP-1 receptor agonists and renal outcomes in patients with diabetes mellitus type 2 and diabetic kidney disease: state of the art

BACKGROUND: Glucagon-like peptide-1 receptor agonists (GLP-1RAs) are highly effective in improving glycaemic control either as monotherapy or in combination with other hypoglycaemic drugs, and have low incidence of side effects, such as hypoglycaemia, nausea and weight gain, thus increasing patients...

Descripción completa

Detalles Bibliográficos
Autores principales:	Granata, Antonio, Maccarrone, Rosario, Anzaldi, Massimiliano, Leonardi, Giuseppe, Pesce, Francesco, Amico, Francesco, Gesualdo, Loreto, Corrao, Salvatore
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	CKJ Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9394722/ https://www.ncbi.nlm.nih.gov/pubmed/36003669 http://dx.doi.org/10.1093/ckj/sfac069

Ejemplares similares

SGLT2 Inhibitors: A Broad Impact Therapeutic Option for the Nephrologist
por: Granata, Antonio, et al.
Publicado: (2022)

Recurrence of immunoglobulin A nephropathy after kidney transplantation: a narrative review of the incidence, risk factors, pathophysiology and management of immunosuppressive therapy
por: Infante, Barbara, et al.
Publicado: (2020)

Management of patients with a failed kidney transplant: what should we do?
por: Fiorentino, Marco, et al.
Publicado: (2020)

Management of post-transplant diabetes mellitus: an opportunity for novel therapeutics
por: Montero, Nuria, et al.
Publicado: (2021)

Immune abnormalities in IgA nephropathy
por: Gentile, Micaela, et al.
Publicado: (2023)

Is there a role in acute kidney injury for FGF23 and Klotho?
por: Mattinzoli, Deborah, et al.
Publicado: (2023)

mRNA as a medicine in nephrology: the future is now
por: Granata, Simona, et al.
Publicado: (2023)

Citation classics: ranking of the top 100 most cited articles in nephrology
por: Montinaro, Vincenzo, et al.
Publicado: (2018)

The new Clinical Kidney Journal, 4 years later
por: Ortiz, Alberto, et al.
Publicado: (2019)

Sweet dreams: therapeutic insights, targeting imaging and physiologic evidence linking sleep, melatonin and diabetic nephropathy
por: Afsar, Baris, et al.
Publicado: (2020)

The genetic map of diabetic nephropathy: evidence from a systematic review and meta-analysis of genetic association studies
por: Tziastoudi, Maria, et al.
Publicado: (2020)

Worsening proteinuria and renal function after intravitreal vascular endothelial growth factor blockade for diabetic proliferative retinopathy
por: Shye, Michael, et al.
Publicado: (2020)

Repurposing drugs for highly prevalent diseases: pentoxifylline, an old drug and a new opportunity for diabetic kidney disease
por: Donate-Correa, Javier, et al.
Publicado: (2022)

GLP-1 receptor agonists in the treatment of type 2 diabetes – state-of-the-art
por: Nauck, Michael A., et al.
Publicado: (2020)

The anaemia treatment journey of CKD patients: from epoetins to hypoxia-inducible factor-prolyl hydroxylase inhibitors
por: Locatelli, Francesco, et al.
Publicado: (2023)

Systemic and targeted steroids for the treatment of IgA nephropathy
por: Locatelli, Francesco, et al.
Publicado: (2023)

Understanding patient needs and predicting outcomes in IgA nephropathy using data analytics and artificial intelligence: a narrative review
por: Schena, Francesco Paolo, et al.
Publicado: (2023)

Mineralocorticoid receptor antagonist use in chronic kidney disease with type 2 diabetes: a clinical practice document by the European Renal Best Practice (ERBP) board of the European Renal Association (ERA)
por: Sarafidis, Pantelis, et al.
Publicado: (2023)

The Latin American Dialysis and Renal Transplantation Registry: report 2019
por: Luxardo, Rosario, et al.
Publicado: (2021)

Step-by-step guide to setting up a kidney replacement therapy registry: the challenge of a national kidney replacement therapy registry
por: Rosa-Diez, Guillermo, et al.
Publicado: (2021)

mTOR-inhibitors and post-transplant diabetes mellitus: a link still debated in kidney transplantation
por: Granata, Simona, et al.
Publicado: (2023)

Expert guidance on the multidisciplinary management of cystinosis in adolescent and adult patients
por: Levtchenko, Elena, et al.
Publicado: (2022)

Efficacy and safety of GLP-1 receptor agonists as add-on to SGLT2 inhibitors in type 2 diabetes mellitus: A meta-analysis
por: Castellana, Marco, et al.
Publicado: (2019)

Update on persistent acute kidney injury in critical illnesses
por: Samoni, Sara, et al.
Publicado: (2023)

The effect of a ketogenic diet on weight loss in CKD: a randomized controlled trial in obese stage G1–3a CKD patients
por: Zoccali, Carmine, et al.
Publicado: (2023)

Late outcomes of renal denervation are more favourable than early ones: facts or fancies?
por: Persu, Alexandre, et al.
Publicado: (2023)

“The Disease Awareness Innovation Network” for chronic kidney disease identification in general practice
por: Pesce, Francesco, et al.
Publicado: (2022)

Role and development of GLP-1 receptor agonists in the management of diabetes
por: Chia, Chee W, et al.
Publicado: (2009)

Effects of GLP-1 receptor agonists on neurological complications of diabetes
por: García-Casares, Natalia, et al.
Publicado: (2023)

Coronavirus disease 2019 in chronic kidney disease
por: D’Marco, Luis, et al.
Publicado: (2020)

Bone mineral density and mortality in end-stage renal disease patients
por: Iseri, Ken, et al.
Publicado: (2020)

A brand-new cardiorenal syndrome in the COVID-19 setting
por: Apetrii, Mugurel, et al.
Publicado: (2020)

Opportunities in the cloud or pie in the sky? Current status and future perspectives of telemedicine in nephrology
por: Stauss, Madelena, et al.
Publicado: (2020)

Evidence in chronic kidney disease–mineral and bone disorder guidelines: is it time to treat or time to wait?
por: Bover, Jordi, et al.
Publicado: (2020)

Are endourological procedures for nephrolithiasis treatment associated with renal injury? A review of potential mechanisms and novel diagnostic indexes
por: Mykoniatis, Ioannis, et al.
Publicado: (2020)

An introduction to joint models—applications in nephrology
por: Chesnaye, Nicholas C, et al.
Publicado: (2020)

Acute kidney injury and adverse outcomes of critical illness: correlation or causation?
por: Girling, Benedict J, et al.
Publicado: (2019)

A new series of advanced-level research methods papers
por: Jager, Kitty J, et al.
Publicado: (2020)

Challenges in primary focal segmental glomerulosclerosis diagnosis: from the diagnostic algorithm to novel biomarkers
por: Jacobs-Cachá, Conxita, et al.
Publicado: (2020)

Acute kidney injury pathology and pathophysiology: a retrospective review
por: Gaut, Joseph P, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_0khepaoqfi2lshpojrngudmb00